641 related articles for article (PubMed ID: 15036237)
21. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
23. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M
J Immunol; 1995 Aug; 155(3):1151-64. PubMed ID: 7636184
[TBL] [Abstract][Full Text] [Related]
24. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
25. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
27. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
29. Thymic regulatory T cells.
Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
[TBL] [Abstract][Full Text] [Related]
30. Human CD4+CD25+ regulatory T cells.
Baecher-Allan C; Viglietta V; Hafler DA
Semin Immunol; 2004 Apr; 16(2):89-98. PubMed ID: 15036232
[TBL] [Abstract][Full Text] [Related]
31. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
Yotsukura J; Huang H; Singh AK; Shichi H
Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
[TBL] [Abstract][Full Text] [Related]
32. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets.
Horwitz DA; Zheng SG; Gray JD
J Leukoc Biol; 2003 Oct; 74(4):471-8. PubMed ID: 14519757
[TBL] [Abstract][Full Text] [Related]
33. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
Chung Y; Lee SH; Kim DH; Kang CY
J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
Park HB; Paik DJ; Jang E; Hong S; Youn J
Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
[TBL] [Abstract][Full Text] [Related]
35. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
36. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
Roncarolo MG; Gregori S; Levings M
Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
[TBL] [Abstract][Full Text] [Related]
37. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
[TBL] [Abstract][Full Text] [Related]
38. CD4(+)CD25high regulatory T cells in human pregnancy.
Saito S; Sasaki Y; Sakai M
J Reprod Immunol; 2005 Apr; 65(2):111-20. PubMed ID: 15811516
[TBL] [Abstract][Full Text] [Related]
39. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
40. Astrocyte-induced regulatory T cells mitigate CNS autoimmunity.
Trajkovic V; Vuckovic O; Stosic-Grujicic S; Miljkovic D; Popadic D; Markovic M; Bumbasirevic V; Backovic A; Cvetkovic I; Harhaji L; Ramic Z; Mostarica Stojkovic M
Glia; 2004 Aug; 47(2):168-79. PubMed ID: 15185395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]